Shaanxi Meibang Pharmaceutical Group Co., Ltd. (SHA:605033)
China
· Delayed Price · Currency is CNY 23.51
+0.61 (2.66%)
Mar 10, 2026, 3:00 PM CST
SHA:605033 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Net Income | 29.78 | 36.86 | 57.56 | 145.09 | 125.74 | 78.73 | Upgrade
|
| Depreciation & Amortization | 20.43 | 20.43 | 20.87 | 15.47 | 12.48 | 10.47 | Upgrade
|
| Other Amortization | 1.92 | 1.92 | 0.35 | 0.35 | 0.07 | 0.1 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.03 | 0.03 | 0.04 | 0.12 | 0.02 | 6.26 | Upgrade
|
| Loss (Gain) From Sale of Investments | -8.23 | -8.23 | -4.58 | -4.04 | -0.91 | -3.02 | Upgrade
|
| Provision & Write-off of Bad Debts | -5.24 | -5.24 | -2.47 | 5.99 | 3.65 | - | Upgrade
|
| Other Operating Activities | -3.91 | 19.83 | 16.49 | 8.19 | 13.65 | 0.17 | Upgrade
|
| Change in Accounts Receivable | 66.49 | 66.49 | 98.49 | -57.22 | -105.49 | -49.96 | Upgrade
|
| Change in Inventory | 67.59 | 67.59 | 85.48 | 92.31 | -293.91 | -48.06 | Upgrade
|
| Change in Accounts Payable | 80.15 | 80.15 | 67.44 | -71.9 | 135.81 | 78.2 | Upgrade
|
| Operating Cash Flow | 249.58 | 280.4 | 334.79 | 126.41 | -108.75 | 74.88 | Upgrade
|
| Operating Cash Flow Growth | -27.90% | -16.25% | 164.84% | - | - | -41.71% | Upgrade
|
| Capital Expenditures | -193.83 | -158.81 | -203.69 | -109.29 | -106.53 | -61.71 | Upgrade
|
| Sale of Property, Plant & Equipment | 0 | 0.01 | - | 0.03 | - | 0.02 | Upgrade
|
| Investment in Securities | -128 | -388 | 80 | 68 | -148 | 12 | Upgrade
|
| Other Investing Activities | 8.63 | 9.33 | 6.51 | 6.86 | 2.61 | 6.2 | Upgrade
|
| Investing Cash Flow | -313.19 | -537.47 | -117.18 | -34.4 | -251.92 | -43.49 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 40 | 204.04 | - | Upgrade
|
| Long-Term Debt Issued | - | 73 | 2.07 | - | - | - | Upgrade
|
| Total Debt Issued | 77 | 73 | 2.07 | 40 | 204.04 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -67.05 | -177 | -40 | Upgrade
|
| Long-Term Debt Repaid | - | -1 | -1.07 | - | - | - | Upgrade
|
| Total Debt Repaid | - | -1 | -1.07 | -67.05 | -177 | -40 | Upgrade
|
| Net Debt Issued (Repaid) | 77 | 72 | 1 | -27.05 | 27.04 | -40 | Upgrade
|
| Issuance of Common Stock | - | - | - | 25.57 | 391.84 | - | Upgrade
|
| Repurchase of Common Stock | - | - | -25.91 | - | - | - | Upgrade
|
| Common Dividends Paid | -21.57 | -28.24 | -29.82 | -26.67 | -3.29 | -0.7 | Upgrade
|
| Other Financing Activities | -14.68 | -18.91 | -3.68 | 69.99 | -65 | -19 | Upgrade
|
| Financing Cash Flow | 40.74 | 24.85 | -58.42 | 41.84 | 350.59 | -59.7 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | - | 0.06 | -0.01 | Upgrade
|
| Net Cash Flow | -22.87 | -232.22 | 159.2 | 133.85 | -10.02 | -28.33 | Upgrade
|
| Free Cash Flow | 55.75 | 121.59 | 131.1 | 17.12 | -215.28 | 13.17 | Upgrade
|
| Free Cash Flow Growth | -65.31% | -7.26% | 665.68% | - | - | -86.09% | Upgrade
|
| Free Cash Flow Margin | 6.40% | 13.73% | 18.75% | 1.89% | -25.55% | 2.32% | Upgrade
|
| Free Cash Flow Per Share | 0.41 | 0.89 | 0.98 | 0.13 | -1.95 | 0.13 | Upgrade
|
| Cash Income Tax Paid | 8.46 | 13.33 | 15.85 | 26.36 | 19.05 | 13.61 | Upgrade
|
| Levered Free Cash Flow | 98.78 | 180.84 | 132.4 | -48.62 | -303.49 | -13.38 | Upgrade
|
| Unlevered Free Cash Flow | 98.8 | 180.85 | 132.64 | -48 | -301.43 | -12.85 | Upgrade
|
| Change in Working Capital | 214.79 | 214.79 | 246.54 | -44.75 | -263.45 | -18.22 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.